Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

Provided By Globe Newswire

Last update: Feb 28, 2022

EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and rare disease therapies, today provided a corporate update and announced financial results for the fourth quarter and full-year ended December 31, 2021.